Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results
Review
[키워드] adverse events
applied
approach
article
base
Betacoronavírus
Betacoronavirus
clinical trial
combater
conditions
convalescent plasma
Convalescent plasma therapy
Coronavirus infections
COVID-19
COVID-19 patients
Critical case
Critically ill patient
database
decrease
disease
drugs
Efficacy
effort
eficácia
Europe
evaluate
Evidence
highlight
Hospitalized
hospitalized patients
immunization
Immunization, passive
Imunização
Imunização passiva
Infecções por coronavírus
Intervention
less
life-threatening
Mortality
MOST
multicenter
nCOV-2019
North America
Oceania
outcome
pacientes com COVID-19
Pacientes hospitalizados
Patient
patients with COVID-19
performed
Placebo
plasma
Plasma convalescente
plasma exchange
protocol
reported
SARS-CoV-2
severe disease
Standard therapy
the SARS-CoV-2
therapy
[DOI] 10.31744/einstein_journal/2021RW6186 PMC 바로가기 [Article Type] Review
[DOI] 10.31744/einstein_journal/2021RW6186 PMC 바로가기 [Article Type] Review